The use of direct oral anticoagulants for primary thromboprophylaxis in ambulatory cancer patients: Guidance from the SSC of the ISTH

J Thromb Haemost. 2019 Oct;17(10):1772-1778. doi: 10.1111/jth.14564. Epub 2019 Jul 28.

Tzu-Fei Wang¹, Jeffrey I Zwicker², Cihan Ay^{3

4}, Ingrid Pabinger³, Anna Falanga^{5

6}, Darko Antic⁷, Simon Noble⁸, Alok A Khorana⁹, Marc Carrier¹⁰, Guy Meyer¹¹

¹ Division of Hematology, Department of Internal Medicine, Ohio State University Wexner Medical Center, Columbus, OH, USA.
² Division of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
³ Clinical Division of Haematology and Haemostaseology, Department of Medicine, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria.
⁴ I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
⁵ Department of Medicine and Surgery, University of Milan Bicocca, Milan, Italy.
⁶ Department of Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo, Italy.
⁷ Clinic for Hematology, Clinical Center Serbia, University of Belgrade, Belgrade, Serbia.
⁸ Marie Curie Palliative Care Research Centre, Cardiff University, Cardiff, Wales, UK.
⁹ Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.
¹⁰ Department of Medicine, Ottawa Hospital Research Institute at the University of Ottawa, Ottawa, ON, Canada.
¹¹ Department of Respiratory Disease, Hopital Europeen Georges Pompidou, AP-HP, INSERM CIC1418, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.

No abstract available

Publication types